A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Clinical trial NCT04035005 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04035005
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-12
- Primary completion
- 2025-01-15
- Enrollment
- 1013
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.